Skip to search formSkip to main content

Expanded Access Study

Known as: EXPANDED ACCESS 
Studies that provide a means for obtaining an experimental drug or device for patients who are not adequately treated by existing therapy, who do not… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
BACKGROUND U.S. physicians may treat a patient with an investigational drug outside of a clinical trial by using the expanded… Expand
Is this relevant?
Review
2018
Review
2018
Individual patients with life-threatening or severely debilitating diseases can petition the U.S. Food and Drug Administration… Expand
Is this relevant?
Review
2018
Review
2018
Summary Individual patients with life-threatening or severely debilitating diseases can petition the U.S. Food and Drug… Expand
Is this relevant?
Review
2018
Review
2018
Summary With drug approval times taking an average of 8 years from entry into clinical trials to full U.S. Food and Drug… Expand
Is this relevant?
2017
2017
When patients are told that standard medical treatment options have been exhausted, their treating physicians may start looking… Expand
Is this relevant?
2017
2017
ObjectiveWe sought to determine the characteristics of “expanded access” and “compassionate use” programs registered in… Expand
  • table 1
Is this relevant?
2016
2016
Because many patients with unresectable basal cell carcinoma (BCC) are aged ≥65 years, this study explores the efficacy and… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 1
Is this relevant?
2016
2016
BackgroundWhen a new intervention or drug is developed, this has to pass through various phases of clinical testing before it… Expand
Is this relevant?
Review
2015
Review
2015
PURPOSE The Food and Drug Administration Expanded Access (EA) program and "Right-to-Try" legislation aim to provide seriously ill… Expand
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Vismodegib, a first-in-class Hedgehog pathway inhibitor, was US Food and Drug Administration (FDA) approved for… Expand
  • figure 1
  • table I
  • table II
  • figure 2
  • figure 3
Is this relevant?